Home » Topics » Regulatory

Regulatory
RSS

NDA submitted for fast-dissolving Zomig

June 7, 2000

Genentech's single-injection clot buster for heart attack approved by FDA

June 7, 2000

Schering AG's Yasmin approved in The Netherlands

June 5, 2000

3M's QVAR asthma inhaler approved by Health Canada

June 5, 2000

BDNF reported to be useful for liver diseases

June 2, 2000

Use of pregabalin and related compounds for mania and bipolar disorder

June 2, 2000

Olux approved for U.S. marketing

June 2, 2000

Anticonvulsants reported useful for alcohol addiction and abuse

June 1, 2000

Janssen evaluating combination therapies for Alzheimer's disease and psychosis

June 1, 2000

Topical formulations of CMI-392, a dual PAF antagonist and 5-LO inhibitor

June 1, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...